{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Complete Remission"},{"categories":[{"measurements":[{"groupId":"OG000","value":"5"}]}],"title":"Progression of Disease (POD)"}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"}],"units":"Participants"}],"groups":[{"description":"HLA Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Leukemia","id":"OG000","title":"HLA Haploidentical Natural Killer Cell Infusion"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"3 Months following treatment","title":"Treatment Efficacy as Defined by Complete or Partial Remission","type":"PRIMARY","unitOfMeasure":"participants"}